Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound

Eli Lilly is cutting prices again for those who pay cash for introductory doses of the weight-loss drug Zepbound. The lowest dose vial will cost $299 a month, that would be a saving of about $50. It’s part of the price war with rival Novo Nordisk. Bloomberg’s Madison Muller reports. (Source: Bloomberg)

Source: Bloomberg Markets.